Allergan, the pharmaceutical company, has appointed Rapp to promote its dermal filler brand Juvederm across Europe and Africa.
Rapp will handle the strategic media planning, buying and search activity for the filler, which is injected under the skin to treat fine lines and volume loss. It won the account following a three-way pitch.
It has been asked to support Allergan’s strategy to differentiate its offer among its core audience of 35- to 39-year-old females, as well as the medical aesthetics healthcare professionals.
Samantha Leese, the senior marketing manager, Allergan, said: "Rapp provided great insight and depth of knowledge for our specific market segments."
In addition, Allergan has asked Rapp to handle media and digital activities in two markets for a number of its disease education initiatives.
Ian Maynard, the managing director of Rapp Media, said: "Allergan’s growth ambitions in 2014 play to our insight-driven global planning and buying capabilities. The differences in maturity and regulatory constraints across the markets mean there’s no one size fits all approach. This is a really exciting account for us to work on."
This article was first published on